Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|9|995-1003

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.9, 2015-09, pp. : 995-1003

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse Reactions to Controlled Release Levodopa/Carbidopa in Older Persons: Case Reports

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 43, Iss. 1, 1995-01 ,pp. : 47-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gastroretentive carbidopa/levodopa, DM‐1992, for the treatment of advanced Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 9, 2015-08 ,pp. : 1222-1228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off

By Findley Leslie J   Lees Andrew   Apajasalo Marjo   Pitkänen Anna   Turunen Heidi  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1005-1014

Informa Healthcare

Access to resources Recommend Favorite

Levodopa––carbidopa intestinal gel for treatment of advanced Parkinson’’s disease

By Fernandez H.H.   Odin P.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 907-919

Informa Healthcare

Access to resources Recommend Favorite

Suicide in Parkinson's Disease Patients Treated With Levodopa‐Carbidopa Intestinal Gel

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1434-1435

John Wiley & Sons Inc

Access to resources Recommend Favorite